Stock BDX BECTON, DICKINSON AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials Becton, Dickinson and Company

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 04:00:01 2024-04-26 pm EDT 		5-day change 1st Jan Change
231.6 USD +0.46% Intraday chart for Becton, Dickinson and Company -1.10% -5.04%
Apr. 05 Becton Dickinson Releases New Image-Enabled Cell Sorters MT
Apr. 05 Becton, Dickinson and Company Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters CI

Valuation

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 68,288 67,447 70,597 63,550 75,002 66,895 - -
Enterprise Value (EV) 1 87,112 82,533 85,924 78,609 89,465 79,726 77,450 74,843
P/E ratio 65 x 85.9 x 35.9 x 37.9 x 52.3 x 33.8 x 28.2 x 25.2 x
Yield 1.22% 1.36% 1.35% 1.56% - 1.61% 1.64% 1.76%
Capitalization / Revenue 3.95 x 3.94 x 3.49 x 3.37 x 3.87 x 3.29 x 3.11 x 2.95 x
EV / Revenue 5.04 x 4.82 x 4.24 x 4.17 x 4.62 x 3.93 x 3.6 x 3.3 x
EV / EBITDA 17 x 17.2 x 14.7 x 15.2 x 13.1 x 13.8 x 12.4 x 11 x
EV / FCF 36.7 x 30.2 x 25.2 x 52.5 x 42.3 x 19.6 x 20.7 x 18.3 x
FCF Yield 2.72% 3.31% 3.98% 1.91% 2.37% 5.11% 4.84% 5.47%
Price to Book 3.24 x 2.87 x 2.95 x 3.21 x - 2.57 x 2.48 x 2.36 x
Nbr of stocks (in thousands) 269,954 289,869 287,190 285,195 290,109 288,902 - -
Reference price 2 253.0 232.7 245.8 222.8 258.5 231.6 231.6 231.6
Announcement Date 11/5/19 11/5/20 11/4/21 11/10/22 11/9/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 17,290 17,117 20,248 18,870 19,372 20,311 21,502 22,705
EBITDA 1 5,126 4,792 5,838 5,160 6,846 5,759 6,247 6,778
EBIT 1 4,372 3,994 4,971 4,362 4,558 4,867 5,340 5,781
Operating Margin 25.29% 23.33% 24.55% 23.12% 23.53% 23.96% 24.84% 25.46%
Earnings before Tax (EBT) 1 1,163 985 2,242 1,783 1,662 2,922 3,385 3,006
Net income 1 1,069 767 2,002 1,689 1,424 2,105 2,543 2,665
Net margin 6.18% 4.48% 9.89% 8.95% 7.35% 10.36% 11.82% 11.74%
EPS 2 3.890 2.710 6.850 5.880 4.940 6.852 8.202 9.190
Free Cash Flow 1 2,373 2,729 3,416 1,498 2,116 4,077 3,748 4,095
FCF margin 13.72% 15.94% 16.87% 7.94% 10.92% 20.07% 17.43% 18.04%
FCF Conversion (EBITDA) 46.29% 56.95% 58.51% 29.03% 30.91% 70.8% 59.99% 60.42%
FCF Conversion (Net income) 221.98% 355.8% 170.63% 88.69% 148.6% 193.71% 147.4% 153.67%
Dividend per Share 2 3.080 3.160 3.320 3.480 - 3.726 3.804 4.065
Announcement Date 11/5/19 11/5/20 11/4/21 11/10/22 11/9/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 5,135 4,995 5,011 4,641 4,761 4,586 4,821 4,878 5,087 4,706 5,038 5,144 5,415 5,011 5,319
EBITDA 1 1,328 1,467 1,362 1,189 1,344 1,469 1,293 1,316 1,928 1,113 1,399 1,503 1,733 1,389 -
EBIT 1 1,086 1,274 1,161 1,009 1,121 1,264 1,077 1,107 1,341 914 1,165 1,267 1,487 1,137 1,272
Operating Margin 21.15% 25.51% 23.17% 21.74% 23.55% 27.56% 22.34% 22.69% 26.36% 19.42% 23.12% 24.63% 27.45% 22.68% 23.92%
Earnings before Tax (EBT) 1 266 723 525 421 321 481 529 471 181 359 622 723 961 541 754
Net income 1 242 655 431 338 265 486 438 392 108 281 492.5 605.3 777.3 518.1 648
Net margin 4.71% 13.11% 8.6% 7.28% 5.57% 10.6% 9.09% 8.04% 2.12% 5.97% 9.78% 11.77% 14.35% 10.34% 12.18%
EPS 2 0.8400 2.280 1.500 1.180 0.9200 1.700 1.530 1.360 0.3700 0.9600 1.630 2.020 2.600 1.960 -
Dividend per Share 0.8300 0.8700 - - - - - - - - - - - - -
Announcement Date 11/4/21 2/3/22 5/5/22 8/4/22 11/10/22 2/2/23 5/4/23 8/3/23 11/9/23 2/1/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 18,824 15,086 15,327 15,059 14,463 12,831 10,555 7,948
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.672 x 3.148 x 2.625 x 2.918 x 2.113 x 2.228 x 1.69 x 1.173 x
Free Cash Flow 1 2,373 2,729 3,416 1,498 2,116 4,077 3,748 4,095
ROE (net income / shareholders' equity) 15.2% 12.8% 16.1% 6.9% 5.58% 14.3% 15.2% 15.8%
ROA (Net income/ Total Assets) 6.07% 6.19% 7.08% 3.16% 2.69% 5.57% 6.46% 7.08%
Assets 1 17,619 12,392 28,265 53,400 52,856 37,800 39,354 37,637
Book Value Per Share 2 78.00 81.10 83.20 69.30 - 90.10 93.50 98.10
Cash Flow per Share 2 12.10 12.50 15.90 8.600 10.40 18.30 23.50 -
Capex 1 957 810 1,231 973 874 910 946 982
Capex / Sales 5.53% 4.73% 6.08% 5.16% 4.51% 4.48% 4.4% 4.32%
Announcement Date 11/5/19 11/5/20 11/4/21 11/10/22 11/9/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
231.6 USD
Average target price
279 USD
Spread / Average Target
+20.48%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-1.93% 24.52B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. BDX Stock
  4. Financials Becton, Dickinson and Company